Form D · Other Technology
Biobot Analytics, Inc.
Cambridge, MA · CIK 0001809780
Offering snapshot reported Jun 6, 2025 · SEC filing
- Reported sold
- $13.5M Offering amount: $13.6M
- Investors reported
- 46 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2025 | Initial | $13,451,355 | No comparison | 46 | SEC filing |
| Nov 17, 2021 | Amendment | $20,833,737 | $4,691,772vs Aug 6, 2021 | 26 | SEC filing |
| Aug 6, 2021 | Initial | $16,141,965 | No comparison | Not reported | SEC filing |
| Apr 17, 2020 | Initial | $6,739,444 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548275
Source: Form D, filed Jun 6, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ann De Witt | Director |
| Newsha Ghaeli | Director, Executive |
| Mariana Guadalupe Matus Garcia | Director, Executive |
| Vivek Pattipati | Director |
| Andrew Perlman | Director |
| Rich Henry Schabowsky | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
501 Massachusetts Avenue
Cambridge, MA, 02139
Cambridge, MA, 02139